In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children
- PMID: 26327630
- PMCID: PMC4639413
- DOI: 10.1016/j.bbmt.2015.08.022
In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children
Abstract
The inclusion of antithymocyte globulin (ATG) in cord blood transplantation is controversial. We evaluated outcomes according to ATG inclusion in 297 children and adolescents with acute lymphoblastic leukemia (ALL) who received myeloablative total body irradiation-based conditioning and either single-unit (74%) or double-unit (26%) grafts. Ninety-two patients (31%) received ATG and 205 (69%) did not. ATG recipients were more likely to be cytomegalovirus seronegative. The incidences of day 100 grades II to IV acute graft-versus-host disease (GVHD; 30% versus 54%, P = .0002) and chronic GVHD (22% versus 43%, P = .0008) were lower with ATG compared with non-ATG regimens. However, day 100 grades III to IV acute GVHD was comparable (11% versus 17%, P = .15). The 3-year incidences of transplant-related mortality (16% versus 17%, P = .98), relapse (17% versus 27%, P = .12), and leukemia-free survival (66% versus 55%, P = .23) in ATG and non-ATG recipients were similar. There were no differences in viral reactivation between treatment groups (60% versus 58%, P = .83). Therefore, the data suggest that incorporation of ATG with myeloablative conditioning regimens may be useful in reducing the risk of acute and chronic GVHD without any deleterious effect on transplant-related mortality, relapse, or leukemia-free survival in children and adolescents with ALL.
Keywords: Acute lymphoblastic leukemia; In vivo T cell depletion; Myeloablative conditioning.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in China.Biol Blood Marrow Transplant. 2017 Sep;23(9):1541-1548. doi: 10.1016/j.bbmt.2017.05.004. Epub 2017 May 9. Biol Blood Marrow Transplant. 2017. PMID: 28499936
-
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.Biol Blood Marrow Transplant. 2017 Sep;23(9):1555-1566. doi: 10.1016/j.bbmt.2017.05.025. Epub 2017 May 25. Biol Blood Marrow Transplant. 2017. PMID: 28552421 Clinical Trial.
-
Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.Biol Blood Marrow Transplant. 2017 Sep;23(9):1498-1508. doi: 10.1016/j.bbmt.2017.05.026. Epub 2017 May 26. Biol Blood Marrow Transplant. 2017. PMID: 28554856
-
Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.Hematology. 2015 Mar;20(2):61-71. doi: 10.1179/1607845414Y.0000000175. Epub 2014 Jul 3. Hematology. 2015. PMID: 24993587 Review.
-
Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation.Biol Blood Marrow Transplant. 2015 Jun;21(6):959-70. doi: 10.1016/j.bbmt.2014.11.676. Epub 2014 Dec 5. Biol Blood Marrow Transplant. 2015. PMID: 25482864 Review.
Cited by
-
Single umbilical cord blood with or without CD34+ cells from a third-party donor in adults with leukemia.Blood Adv. 2017 Jun 20;1(15):1047-1055. doi: 10.1182/bloodadvances.2017006999. eCollection 2017 Jun 27. Blood Adv. 2017. PMID: 29296747 Free PMC article.
-
Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes.Biol Blood Marrow Transplant. 2017 Oct;23(10):1714-1721. doi: 10.1016/j.bbmt.2017.06.023. Epub 2017 Jul 3. Biol Blood Marrow Transplant. 2017. PMID: 28684372 Free PMC article. Clinical Trial.
-
Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults.Clin Hematol Int. 2020 Jan 28;2(1):5-12. doi: 10.2991/chi.d.200115.001. eCollection 2020 Mar. Clin Hematol Int. 2020. PMID: 34595437 Free PMC article. Review.
-
Leukemia-free survival in myeloid leukemia, but not in lymphoid leukemia, is predicted by early CD4+ reconstitution following unrelated cord blood transplantation in children: a multicenter retrospective cohort analysis.Bone Marrow Transplant. 2016 Oct;51(10):1376-1378. doi: 10.1038/bmt.2016.116. Epub 2016 May 9. Bone Marrow Transplant. 2016. PMID: 27159172 No abstract available.
-
Single cord blood transplantation in Japan; expanding the possibilities of CBT.Int J Hematol. 2019 Jul;110(1):39-49. doi: 10.1007/s12185-019-02672-4. Epub 2019 May 31. Int J Hematol. 2019. PMID: 31152417 Review.
References
-
- Haidinger M, Geyeregger R, Poglitsch M, et al. Antithymocyte globulin impairs T-cell/antigen-presenting cell interaction: disruption of immunological synapse and conjugate formation. Transplantation. 2007;84(1):117–121. - PubMed
-
- Monti P, Allavena P, Di Carlo V, Piemonti L. Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol. 2003;3(2):189–196. - PubMed
-
- Gillet-Hladky S, de Carvalho CM, Bernaud J, Bendahou C, Bloy C, Rigal D. Rabbit antithymocyte globulin inhibits monocyte-derived dendritic cells maturation in vitro and polarizes monocyte-derived dendritic cells towards tolerogenic dendritic cells expressing indoleamine 2,3-dioxygenase. Transplantation. 2006;82(7):965–974. - PubMed
-
- Fang L, Fehse B, Engel M, Zander A, Kroger N. Antithymocyte globulin induces ex vivo and in vivo depletion of myeloid and plasmacytoid dendritic cells. Transplantation. 2005;79(3):369–371. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources